AstraZeneca PLC — Major Shareholding Notification 2014

May 7, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5197G

AstraZeneca PLC

07 May 2014

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			AstraZeneca PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		The Capital Group Companies, Inc.
4. Full name of shareholder(s) (if different from 3.):iv		See Schedule A
5. Date of the transaction and date on which the threshold is crossed or reached: v		1 May 2014
6. Date on which issuer notified:		2 May 2014
7. Threshold(s) that is/are crossed or reached: vi, vii		Below 3%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction						Resulting situation after the triggering transaction
Number of Shares			Number of Voting Rights			Number of shares		Number of voting rights			% of  voting rights x
Direct		Direct xi		Indirect xii	Direct			Indirect
Ordinary Shares (ISIN: GB0009895292)	38,227,146			38,227,146							35,130,146				2.7838%
ADRs (ISIN: US0463531089)	2,569,300			2,569,300							2,371,800				0.1879%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date xiii		Exercise/ Conversion Period xiv					Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date xvii		Exercise/ Conversion period xviii			Number of voting rights instrument refers to				% of voting rights xix, xx
													Nominal			Delta
Total (A+B+C)
Number of voting rights								Percentage of voting rights
37,501,946								2.9717%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
See Schedule A
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:	Martin Bennett, Assistant Company Secretary
15. Contact telephone number:	020 7604 8157

Schedule A

As of 1 May 2014

AstraZeneca PLC

	Number of Shares	Percent of Outstanding
The Capital Group Companies, Inc. ("CG") holdings	37,501,946	2.972%
Holdings by CG Management Companies and Funds:
Capital Guardian Trust Company	15,424	0.001%
Capital International Limited	7,100	0.001%
Capital International Sàrl	1,092	0.000%
Capital Research and Management Company	37,478,330	2.970%

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBUGDUDUGBGSR